AC Immune (NASDAQ:ACIU) Stock Price Passes Below Fifty Day Moving Average – Here’s What Happened

AC Immune SA (NASDAQ:ACIU)’s stock price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $2.71 and traded as low as $2.60. AC Immune shares last traded at $2.64, with a volume of 161,167 shares.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and set a $16.00 price objective on shares of AC Immune in a report on Friday, November 15th.

AC Immune Price Performance

The firm has a market capitalization of $261.20 million, a PE ratio of -5.74 and a beta of 1.30. The company’s fifty day simple moving average is $2.71 and its 200 day simple moving average is $3.07.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Squarepoint Ops LLC bought a new position in shares of AC Immune in the fourth quarter worth $118,000. Two Sigma Advisers LP purchased a new stake in AC Immune during the 4th quarter worth about $36,000. Cantor Fitzgerald L. P. bought a new position in AC Immune in the 4th quarter worth about $68,000. Jane Street Group LLC bought a new position in AC Immune in the 4th quarter worth about $66,000. Finally, Northern Trust Corp purchased a new position in AC Immune during the 4th quarter valued at about $1,088,000. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

About AC Immune

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.